AI assistant
Vitrolife Director's Dealing 2020
2989_iss_2020-02-11_5fdb332d-b9d1-46b3-a0c9-41047e962715.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Press Release 11 February 2020 Gothenburg, Sweden
Vitrolife´s CEO sells a portion of his shareholding
Vitrolife's CEO Thomas Axelsson has today sold 50,000 shares worth SEK 9.45 million. The remaining number of shares amounts to 50,500 shares.
"The Vitrolife share has developed very positively since I acquired the shares in 2012 and I therefore choose to realize part of the profit for private financial reasons," says Thomas Axelsson, CEO of Vitrolife AB. The transaction will be reported to The Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations.
Gothenburg, February 11, 2020 VITROLIFE AB (publ) Thomas Axelsson, CEO
Contact persons:
Thomas Axelsson, CEO, tel: +46 31 721 80 01 Mikael Engblom, CFO, tel: +46 31 721 80 14
___________________________________________________________________________________________________________________________________ Vitrolife is an international medical device Group. Vitrolife develops, produces and markets products for assisted reproduction.
Vitrolife has approximately 400 employees and the company's products are sold in approximately 110 markets. The company is headquartered in Gothenburg, Sweden, and there are also offices in Australia, Belgium, China, Denmark, France, Germany, Italy, Japan, United Kingdom and USA. The Vitrolife share is listed on NASDAQ Stockholm.
Vitrolife AB (publ), Box 9080, SE-400 92 Gothenburg. Corporate ID number 556354-3452. Tel: +46 31 721 80 00. Fax: +46 31 721 80 99. E-mail: [email protected]. Website: www.vitrolife.com
_____________________________________________________________________________________________________
This information is information that Vitrolife AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 12:00 CET on February 11, 2020.
This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.